Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Prothena Corp (PRTA)

Prothena Corp (PRTA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,724,444
  • Shares Outstanding, K 46,594
  • Annual Sales, $ 850 K
  • Annual Income, $ -111,140 K
  • 60-Month Beta 1.22
  • Price/Sales 8.41
  • Price/Cash Flow N/A
  • Price/Book 3.76
Trade PRTA with:

Options Overview Details

View History
  • Implied Volatility 82.26% ( -12.79%)
  • Historical Volatility 63.85%
  • IV Percentile 34%
  • IV Rank 29.28%
  • IV High 161.89% on 01/25/21
  • IV Low 49.30% on 01/27/21
  • Put/Call Vol Ratio 0.41
  • Today's Volume 24
  • Volume Avg (30-Day) 131
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 796
  • Open Int (30-Day) 624

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/21
See More
  • Average Estimate -0.71
  • Number of Estimates 4
  • High Estimate -0.52
  • Low Estimate -0.84
  • Prior Year -0.77
  • Growth Rate Est. (year over year) +7.79%

Price Performance

See More
Period Period Low Period High Performance
1-Month
35.04 +4.88%
on 01/12/22
50.06 -26.58%
on 12/31/21
-10.24 (-21.79%)
since 12/17/21
3-Month
35.04 +4.88%
on 01/12/22
63.13 -41.79%
on 10/25/21
-25.90 (-41.34%)
since 10/19/21
52-Week
10.72 +242.82%
on 02/01/21
79.75 -53.92%
on 09/27/21
+23.01 (+167.47%)
since 01/19/21

Most Recent Stories

More News
5 Biotech Stocks That More Than Doubled This Year

The biotech sector has been in focus through 2021 as vaccine makers like Moderna (MRNA) BioNTech (BNTX), and other companies like Dynavax (DVAX), Prothena (PRTA) and Intellia (NTLA) put up an exemplary...

DVAX : 12.69 (-0.31%)
MRNA : 178.90 (-4.13%)
PRTA : 35.74 (-3.43%)
NTLA : 84.23 (-1.83%)
BNTX : 165.01 (-2.49%)
Truck Tech: Rare earth alternative edition

Truck Tech is a weekly newsletter focusing on autonomous, connected and electric innovations in the trucking ecosystem for fleets.

CMI : 231.92 (-1.73%)
PRTA : 35.74 (-3.43%)
Prothena to Participate in JMP Securities Hematology and Oncology Summit

DUBLIN, Ireland, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust...

PRTA : 35.74 (-3.43%)
Cassava (SAVA) Down on Report of SEC Investigation Into AD Program

Cassava (SAVA) tanks on reports of an investigation by the SEC related to data reports on its AD candidate.

BIIB : 231.77 (-0.87%)
PRTA : 35.74 (-3.43%)
QTRX : 29.28 (-2.98%)
SAVA : 40.25 (-2.97%)
Prothena (PRTA) Q3 Earnings Miss, Pipeline Progress in Focus

Prothena misses on earnings and revenues in the third quarter of 2021. Nevertheless, the company's progress with its AD pipeline is encouraging.

RHHBY : 49.9250 (-0.21%)
BMY : 65.14 (+0.39%)
NVO : 97.87 (+1.54%)
PRTA : 35.74 (-3.43%)
Prothena (PRTA) Q3 Earnings and Revenues Miss Estimates

Prothena (PRTA) delivered earnings and revenue surprises of -5.33% and -0.64%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

PRTA : 35.74 (-3.43%)
Prothena to Report Third Quarter 2021 Financial Results on November 4th

DUBLIN, Ireland, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical company with a robust pipeline of novel...

PRTA : 35.74 (-3.43%)
VRTX vs. PRTA: Which Stock Is the Better Value Option?

VRTX vs. PRTA: Which Stock Is the Better Value Option?

VRTX : 231.29 (+0.10%)
PRTA : 35.74 (-3.43%)
Prothena (PRTA) Riding High on Alzheimer's Disease Pipeline

Prothena (PRTA) has promising candidates for Alzheimer's disease in its pipeline. The successful development of the candidates will be a big boost for the company.

BIIB : 231.77 (-0.87%)
RHHBY : 49.9250 (-0.21%)
BMY : 65.14 (+0.39%)
PRTA : 35.74 (-3.43%)
VRTX vs. PRTA: Which Stock Should Value Investors Buy Now?

VRTX vs. PRTA: Which Stock Is the Better Value Option?

VRTX : 231.29 (+0.10%)
PRTA : 35.74 (-3.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Prothena Corporation plc is a biotechnology company focused on the discovery and development of therapeutic monoclonal antibodies for disease-causing proteins. The Company is developing the following programs: NEOD001 for Amyloidosis, NEOD002 for Parkinson's disease, MCAM for Inflammatory disease and...

See More

Key Turning Points

3rd Resistance Point 41.23
2nd Resistance Point 40.32
1st Resistance Point 38.67
Last Price 35.74
1st Support Level 36.10
2nd Support Level 35.19
3rd Support Level 33.54

See More

52-Week High 79.75
Fibonacci 61.8% 53.38
Fibonacci 50% 45.23
Fibonacci 38.2% 37.09
Last Price 35.74
52-Week Low 10.72

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar